SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021964
Filing Date
2022-08-11
Accepted
2022-08-11 07:06:29
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1193653
2 ex10-1.htm EX-10.1 17456
3 ex31-1.htm EX-31.1 26280
4 ex31-2.htm EX-31.2 25138
5 ex32-1.htm EX-32.1 9121
6 ex32-2.htm EX-32.2 9032
  Complete submission text file 0001493152-22-021964.txt   5038173

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cing-20220630.xsd EX-101.SCH 34752
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cing-20220630_cal.xml EX-101.CAL 54734
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cing-20220630_def.xml EX-101.DEF 140314
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cing-20220630_lab.xml EX-101.LAB 284821
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cing-20220630_pre.xml EX-101.PRE 219718
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 823070
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40874 | Film No.: 221153641
SIC: 2834 Pharmaceutical Preparations